Vein Therapy News Vein Therapy News
  • Home
  • Physicians
  • Digital Issue
    • Latest Issue
    • Back Issues
  • Events
  • Industry News
  • Advertise
  • Subscribe
  • Advisory Board
  • Contact
  • Home
  • Physicians
  • Digital Issue
    • Latest Issue
    • Back Issues
  • Events
  • Industry News
  • Advertise
  • Subscribe
  • Advisory Board
  • Contact
  • 10 Feb 2023 Has your practice seen an increase in blood clots since the COVID vaccines became available?
  • 10 Feb 2023 Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients
  • 10 Feb 2023 Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA
  • 10 Feb 2023 Corindus rebranded as Siemens Healthineers Endovascular Robotics
  • 12 Dec 2022 Cook Medical Appoints John A. Kaufman as Chief Medical Officer
  • 12 Dec 2022 Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage
  • 12 Dec 2022 Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study
  • 11 Aug 2022 Starting a vein practice? Start here!
  • News

    Has your practice seen an increase in blood clots since the COVID vaccines became available?

    Vein Therapy News — February 10, 2023
  • Siemens Healthineers
    News

    Corindus rebranded as Siemens Healthineers Endovascular Robotics

    Vein Therapy News — February 10, 2023
  • Dr. John A. Kaufman
    News

    Cook Medical Appoints John A. Kaufman as Chief Medical Officer

    Vein Therapy News — December 12, 2022
  • Embocubes
    News

    Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

    Vein Therapy News — December 12, 2022
  • Vesalio device
    News

    Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study

    Vein Therapy News — December 12, 2022
  • ScleroTech Vein Therapy Solutions
    The Practice

    Starting a vein practice? Start here!

    Vein Therapy News — August 11, 2022
  • Center for Vein Restoration. VISION National Clinical Convention
    News

    VISION 2022

    Vein Therapy News — March 3, 2022

Latest Posts

Embocubes
12 Dec 2022

Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

Merit Medical Systems, Inc. announced the enrollment of the first patient in the company’s prospective, observational study of EmboCube embolization gelatin to control bleeding or hemorrhage. The EmboCube Embolization Gelatin study is designed to enroll 100 patients across multiple centers in Australia and France. The company advised that EmboCube is

Vein Therapy News 0
Vesalio device
12 Dec 2022

Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study

Vesalio announced that data on the use of the company’s NeVa thrombectomy device were published by Arsida Bajrami, MD, et al in Interventional Neuroradiology. The company stated that the NeVa platform is designed to consistently achieve first-pass recanalization in stroke by effectively removing all types of neurovascular clots from a

Vein Therapy News 0
ScleroTech Vein Therapy Solutions
11 Aug 2022

Starting a vein practice? Start here!

Quality Training All Treatment Modalities You, your staff, your patients in the comfort of your own office. Real hands on training! Our on-site consultant Joyce Vining RVT, LPN 25 years experience treating vein disease. Venous Ultrasound | Endovenous Ablation | Phlebectomy | Sclerotherapy Need Office Forms, Photos, and Patient Education?

Vein Therapy News 0
15 Jul 2022

FDA Breakthrough Device designation

Cook Medical announced that its Thoraco+ endovascular system has received Breakthrough Device designation from the FDA. The company describes Thoraco+ as a next- generation, off-the-shelf device in the Zenith platform, indicated for patients with thoracoabdominal aortic aneurysms (Crawford classification I-IV). It has four side branches for the celiac, superior mesenteric,

Vein Therapy News 0
15 Jul 2022

Alucent’s natural vascular scaffolding to be evaluated in ACTIVATE II FIH trial

Alucent Biomedical Inc. announced that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate the safety and efficacy of AlucentNVS, the company’s natural vascular scaffolding device. According to the company, the ACTIVATE II trial will enroll up to 50 patients at up to

Vein Therapy News 0
Page :
1 2 3 4 5 … 61
  • Business News
    146
  • Case Studies
    23
  • Education
    90
  • Events
    83
  • Government
    81
  • LYMPHEDEMA
    02
  • News
    226
  • Payers
    63
  • Physicians
    134
  • Product News
    62
  • Researchers
    59
  • SecondLook
    28
  • Subscription
    02
  • The Practice
    24
  • VTN Advisory Board
    05

SITE SPONSORS

Dr. John A. Chuback’s Podcast – Click Here

ROGER HOGUE, MD, HAS CONDUCTED A NEW STUDY THAT MAKES THE CASE THAT PCF FOAM STRUCTURE AND VISUAL FOAM QUALITY IS AS GOOD OR BETTER THAN PROPRIETARY “FOAM IN A CAN.”
CLICK HERE FOR THE STUDY

LATEST REVIEWS

  • Embocubes
    News

    Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

  • Vesalio device
    News

    Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study

  • ScleroTech Vein Therapy Solutions
    The Practice

    Starting a vein practice? Start here!

  • News

    FDA Breakthrough Device designation

  • News

    Alucent’s natural vascular scaffolding to be evaluated in ACTIVATE II FIH trial

  • Home
  • Physicians
  • Events
  • Latest Issue
  • Industry News
  • Subscribe
  • Advisory Board
  • Advertise
  • Contact
  • Privacy Policy
  • PHYSICIAN-COMPOUNDED FOAM
Copyright ©, 2020 Vein Therapy News. Publications & Communications, LP. All Rights Reserved. Designated trademarks and brands are the property of their respective owners.


SHARE

Home